Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
883.00    -3.00 (-0.34%)
Bid:
882.00
Ask:
885.00
Spread: 3.00 (0.34%)
Market Cap: £831.31m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

9 Jul 2026 07:00

RNS Number : 6021L
Polar Capital Holdings PLC
09 July 2026
 

9 July 2026

Polar Capital Holdings plc

AuM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset manager, provides below a quarterly, unaudited summary of its Assets under Management ("AuM").

 

Group AuM (unaudited)

 

Polar Capital reports that as at 30 June 2026 its AuM was £45.0bn compared to £30.6bn at the end of March 2026, an increase of 47% over the quarter. In the quarter, AuM increased by net inflows of £2.5bn and fund performance and market movements of £11.9bn.

 

AuM movement in three months to 30 June 2026

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated Mandates

(£m)

Total

(£m)

AuM at 1 April 2026

23,424

6,605

604

30,633

Net flows

2,412

(46)

94

2,460

Market movement

and fund performance

8,737

3,035

128

11,900

Total AuM at 30 June 2026

34,573

9,594

826

44,993

 

 

Iain Evans, Chief Executive, commented:

 

"Momentum has continued since the 19 June AuM update included in our Annual Results announcement, with Group AuM of £45.0bn as at 30 June 2026, up 47% from £30.6bn at 31 March 2026. This reflected net inflows of £2.5bn and positive market movements and investment performance of £11.9bn over the quarter. Strong absolute and relative performance from our Technology, Artificial Intelligence and Smart Energy strategies was a key contributor, supported by high-conviction thematic positioning.

 

"Client demand was led by our Technology and AI funds, with positive contributions from Healthcare, Smart Energy, Global Absolute Return and Japan Value. Net outflows were primarily from Emerging Markets Stars and Global Insurance, with redemptions remaining largely client specific.

 

"We continue to see a supportive environment for specialist active management, as markets broaden and elevated stock-level dispersion strengthens the case for high-conviction, differentiated strategies.

 

"This progress provides a strong start to the new financial year. With significant fund capacity across our diverse range of specialist active strategies, we remain focused on converting client demand into durable net flows and delivering long-term value for clients and shareholders."

 

 

 

For further information please contact:

 

Polar Capital

Iain Evans (Chief Executive)Samir Ayub (Chief Financial Officer)

+44 (0)20 7227 2700

 

Deutsche Numis - Nomad and Joint Broker

Charles Farquhar

Duncan Monteith

Rajesh Iyer

 

 

+44 (0)20 7545 8000

 

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Thomas Philpott

 

 

+44 (0)20 3597 8680

Camarco - PR

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

+44 (0)20 3757 4980

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANXPEFLKEFA
Date   Source Headline
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results
19th Oct 20222:52 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSAuM Update
29th Sep 202210:33 amRNSHolding(s) in Company
7th Sep 20224:18 pmRNSResult of AGM
31st Aug 20222:03 pmRNSForm 8.3 - Diurnal Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.